GC
TWST icon

Globeflex Capital’s Twist Bioscience TWST Stock Holding History

Globeflex Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,211
Closed -$126K – 462
2025
Q1 		$126K Buy
+3,211
New +$145K 0.01% 360

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Globeflex Capital's TWST Position: Q2 2025 in Review

Globeflex Capital sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 3,211 shares — an estimated $126K sold.

Globeflex Capital first reported a position in TWST in Q1 2025 and held it in 1 quarter. The position peaked at $126K in Q1 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Globeflex Capital reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Globeflex Capital sold 3,211 Twist Bioscience shares in Q2 2025, an estimated $126K.
  • Globeflex Capital first reported a position in Twist Bioscience in Q1 2025 and held it in 1 quarter.
  • Globeflex Capital's Twist Bioscience position peaked at $126K in Q1 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Globeflex Capital's 13F filing for Q2 2025, filed 14 Aug 2025.